Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Response to [ 177 Lu]Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients presenting with only lymph node metastases.
Zisser L, Yu J, Oszwald A, Wollenweber T, Kretschmer-Chott E, Grubmüller B, Kramer G, Shariat SF, Mitterhauser M, Vraka C, Hacker M, Haug AR, Rasul S. Zisser L, et al. Among authors: kramer g. Nucl Med Commun. 2022 Nov 1;43(11):1113-1120. doi: 10.1097/MNM.0000000000001611. Epub 2022 Sep 19. Nucl Med Commun. 2022. PMID: 36120814 Free PMC article.
Prognostic value of tissue and circulating levels of IMP3 in prostate cancer.
Szarvas T, Tschirdewahn S, Niedworok C, Kramer G, Sevcenco S, Reis H, Shariat SF, Rübben H, vom Dorp F. Szarvas T, et al. Among authors: kramer g. Int J Cancer. 2014 Oct 1;135(7):1596-604. doi: 10.1002/ijc.28808. Epub 2014 Mar 4. Int J Cancer. 2014. PMID: 24615121 Free article.
Prognostic effect of serum and tissue YKL-40 levels in bladder cancer.
Tschirdewahn S, Reis H, Niedworok C, Nyirady P, Szendröi A, Schmid KW, Shariat SF, Kramer G, vom Dorp F, Rübben H, Szarvas T. Tschirdewahn S, et al. Among authors: kramer g. Urol Oncol. 2014 Jul;32(5):663-9. doi: 10.1016/j.urolonc.2014.02.004. Epub 2014 May 9. Urol Oncol. 2014. PMID: 24814404
Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
Lucca I, Rouprêt M, Kluth L, Rink M, Tilki D, Fajkovic H, Kassouf W, Hofbauer SL, de Martino M, Karakiewicz PI, Briganti A, Trinh QD, Seitz C, Fritsche HM, Burger M, Lotan Y, Kramer G, Shariat SF, Klatte T. Lucca I, et al. Among authors: kramer g. BJU Int. 2015 May;115(5):722-7. doi: 10.1111/bju.12829. Epub 2015 Jan 26. BJU Int. 2015. PMID: 24905084
Circulating and Tissue Expression Levels of YKL-40 in Renal Cell Cancer.
Vom Dorp F, Tschirdewahn S, Niedworok C, Reis H, Krause H, Kempkensteffen C, Busch J, Kramer G, Shariat SF, Nyirady P, Rübben H, Szarvas T. Vom Dorp F, et al. Among authors: kramer g. J Urol. 2016 Apr;195(4 Pt 1):1120-5. doi: 10.1016/j.juro.2015.09.084. Epub 2015 Oct 8. J Urol. 2016. PMID: 26454102
Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy.
Fajkovic H, Mathieu R, Lucca I, Hiess M, Hübner N, Al Hussein Al Awamlh B, Lee R, Briganti A, Karakiewicz P, Lotan Y, Roupret M, Rink M, Kluth L, Loidl W, Seitz C, Klatte T, Kramer G, Susani M, Shariat SF. Fajkovic H, et al. Among authors: kramer g. Urol Oncol. 2016 May;34(5):233.e1-6. doi: 10.1016/j.urolonc.2015.10.013. Epub 2016 Mar 10. Urol Oncol. 2016. PMID: 26973136
1,399 results